Patent Number

CA2268372 A1 1998-04-16

Compositions and methods for treating viral infections
Methods and compositions for treatment, diagnosis, and prevention of a virus comprise administering to a patient antibodies which react with regions of viral proteins and result in neutralization of infectivity and inactivation of functionally essential events in the life cycle of the virus.The antibodies recognize viral epitopes which fail to elicit an immune response in man when encountered through infection or naturally through the environment.In a preferred embodiment, the invention provides compositions and methods useful in the treatment and diagnosis of human immunodeficiency virus (HIV) infections.		©Questel

FamPat family

Publication Number		Type	Publi.Date	Links
	EP0939835	A1	1999-09-08
	STG:	(A1) Application published with search report
	AP:	1997EP-0910856
	EP0939835	A4	2004-10-27
	STG:	(A4) Supplementary search report
	AP:	1997EP-0910856
	US20040141996	A1	2004-07-22
	STG:	(A1) Application published
	AP:	2003US-10695112
	US6043347	A	2000-03-28
	STG:	(A) Patents Granted before 2001-04-15
	AP:	1997US-08948782
	US6258599	B1	2001-07-10
	STG:	(B1) Granted patent as first publication
	AP:	2000US-09482612
	US6335017	B1	2002-01-01
	STG:	(B1) Granted patent as first publication
	AP:	2000US-09677554
	US20020086034	A1	2002-07-04
	STG:	(A1) Application published
	AP:	2001US-09985581
	US6670181	B2	2003-12-30
	STG:	(B2) Granted patent as second publication
	AP:	2001US-09985581
	US20070154917	A1	2007-07-05
	STG:	(A1) Application published
	AP:	2006US-11605017
	US8110203	B2	2012-02-07
	STG:	(B2) Granted patent as second publication
	AP:	2006US-11605017
PCT	WO98/15658	A1	1998-04-16
	STG:	(A1) Published application with search report
	AP:	1997WO-US18257
	JP2001502315	A	2001-02-20
	STG:	(A) Published application
	AP:	1998JP-0517749
	JP2009080118	A	2009-04-16
	STG:	(A) Published application
	AP:	2008JP-0259812
	BR9712289	A	1999-08-31
	STG:	(A) Published application
	AP:	1997BR-0012289
	HK1023371	A1	2000-09-08
	STG:	(A1) Patent application
	AP:	2000HK-0102583
	NZ334941	A	2000-11-24
	STG:	(A) Published application
	AP:	1997NZ-0334941
	MXPA02010374	A	2003-04-25
	STG:	(A) Patent application
	AP:	2002MX-PA10374
	CA2268372	A1	1998-04-16
	STG:	(A1) Application laid open
	AP:	1997CA-2268372
	CA2268372	C	2012-11-27
	STG:	(C) Patent (second level)
	AP:	1997CA-2268372
	AU4813197	A	1998-05-05
	STG:	(A) Open to public inspection
	AP:	1997AU-0048131
	AU732809	B2	2001-05-03
	STG:	(B2) Patent preceeded by A1
	AP:	1997AU-0048131
	SG65162	A1	1999-06-22
	STG:	(A1) Patent Application
	AP:	1999SG-0017899
	SG65162	B	2002-02-22
	STG:	(B) Patent Granted
	AP:	1999SG-0017899
	CN1234078	A	1999-11-03
	STG:	(A) Published application
	AP:	1997CN-0198743
	CN1327896	C	2007-07-25
	STG:	(C) Granted patent for invention
	AP:	1997CN-0198743
	KR2000-0048994	A	2000-07-25
	STG:	(A) Published application
	AP:	1999KR-7003052
	KR10-0547049	B1	2006-02-01
	STG:	(B1) Patent specification
	AP:	1999KR-7003052
	KR10-2006-0041157	A	2006-05-11
	STG:	(A) Published application
	AP:	2005KR-7016920
	KR10-0667121	B1	2007-01-12
	STG:	(B1) Patent specification
	AP:	2005KR-7016920

First Date of Grant

2000-03-28

2001-07-10

2002-01-01

2003-12-30

2012-02-07

2001-05-03

2002-02-22

2006-02-01

2007-01-12

2007-07-25

2012-11-27

Inventor

GELDER FRANK B

All applicant/assignee

Probe International ([US])
Probe International ([US])

Probe International Inc.

Probe International Inc. ([US])

Probe International Inc. ([US])
Virionyx Corporation ([NZ])

GELDER FRANK B.

GELDER FRANK B
Innate Therapeutics Limited ([NZ])

PROBE INTERNATIONAL ([US])

Probe International

PROBE INTERNATIONAL

INNATE IMMUNOTHERAPEUTICS LIMITED
PARK PACIFIC INVESTMENTS PTY LIMITED
ALI EL JAM
ADVANCE GROUP INVESTMENTS PTY LIMITED
ALFRED BOWERMAN
RICHARD BELL
JOHN LEONARD BUTLER
ANGIE ROSS
AMGAD GHABRIAL
THOMAS WHITELEY
MONIKA ALLAN
STUART ALLAN
SUNNY BART INVESTMENTS PTY LIMITED
MAHA MIKHAIL
BRETT LOCKER
SEALY VENTURE CAPITAL FUND
MAHMOUD HAMAD
ASSAD MALEK
MOUNIR HANNA
BRIDGECORP AUSTRALIA PTY LIMITED
ADRIAN WHITING
NABIL AGAIBY
HANI BITTAR
TONY HASSAN NOUN
MOSTON PROPERTIES PTY LIMITED
NAGWA MORRIS
GRAEME WILLIAM MORGAN
PAM LAIDLAW
TIMOTHY DWYER
PETER JAN DUVAL
STEVEN ANDREW BLOME
FARID NASSIF
SHERIF RIZKALLAH
DINH NGUYEN
ELHAM NASHED
SHERIF MICHAEL
SAMIR MICHAEL
ANITA LUI
GLENN HAIFER
DAVID GIDDEY
LOURICE GHALY
RAAFAT GHALY
MICHAEL GRANT
VINCENT FAYAD
KHUSHROO DASTUR
HANI BOTROS
JOHN GERARD GROUNDS
ADVANCE COMMERCIAL INVESTMENTS PTY LIMITED
DEAN CHARLES CORNISH
DAGANUR BIOTECHNOLOGY PTY LIMITED
ZACHARIA INVESTMENTS PTY LIMITED
RONALD EDWARD GRISTWOOD
ACN 083 017 127 PTY LIMITED
BRONAM INVESTMENTS PTY LIMITED
NEIL ROBERT CUSSEN
CRAVEL PTY LIMITED
GARY KENNETH URWIN
NABIL ABDELMALEK
ODETTE ABDELSAYED
WANIS WANIS
JEFFREY BRYANT
VICTOR BOARD AND GERALDINE STUART
TALON SYDNEY PTY LIMITED
ARANA OFFSET PTY LIMITED
MARTIN JUDE
STEPHEN LANGSHAW
DENNIS GLENN
MELEDONOS INVESTMENTS PTY LTD
CARL BRYANT
DAVID RATCLIFFE
GARY HOLBROOK
DARYL JOHN, CAROL ROSE, ROBERT LINDSAY, JOAN CAROLE PRYKE

PROBE INTERNATIONAL ([US])
PROBE INTERNATIONAL ([US])

PROBE INTERNATIONAL
PROBE INTERNATIONAL

PROBE INTERNATIONAL

PROBE INTERNATIONAL
PROBE INTERNATIONAL ([US])

PROBE INTERNATIONAL ([US])
PROBE INTERNATIONAL ([US])

Priority Details

1996US-60028194 1996-10-101997US-08948782 1997-10-101997WO-US18257 1997-10-101999KR-7003052 1999-04-092000US-09482612 2000-01-142000US-09677554 2000-10-022001US-09985581 2001-11-052003US-10695112 2003-10-282006US-11605017 2006-11-28

Designated States

Contracting States: AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

National States: AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW
ARIPO: GH KE LS MW SD SZ UG ZW
EPO: AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

�Questel